Form 4 for PYXS Pyxis Oncology, Inc.
Accepted 2023-11-30 00:00:00 ET · period of report 2023-11-29 · accession 0001209191-23-056969 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-30 | 2023-11-29 | PYXS | Connealy Pamela Ann | CFO, COO | F - Tax | $1.40 | -36.9K | 781.6K | -5% | -$51.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-29 | F | D | 36,949 | $1.40 | 781,583 | D | — | — | (F1) Represents shares withheld to cover taxes due upon the vesting of certain restricted stock units. |